Thiosemicarbazones and its derivatives received a great pharmaceutical importance due to their prominent biological activities. Methods: A series of disubstituted thiosemicarbazone derivatives (1-12) were designed and synthesized as pure compounds in good yield. All the synthesized compounds were analyzed by spectral data. The anticancer activity of all the compounds was performed against breast cancer MCF-7
背景:
硫代
氨基
咔唑及其衍
生物因其突出的
生物活性而在制药上具有重要意义。 方法:设计并合成了一系列双取代的
硫代半碳酰胺衍
生物(1-12),其收率为纯净。通过光谱数据分析所有合成的化合物。所有化合物的抗癌活性均针对乳腺癌MCF-7和
MDA-MB-231
细胞系进行。 结果:大多数化合物显示出对乳腺癌MCF-7和
MDA-MB-231
细胞系的活性,分别为(IC50 = 12.25 µM ‒ 185.35 µM)和(IC50 = 12.97 µM ‒ 107.33 µM)。化合物9分别针对MCF-7和
MDA-MB-231
细胞系(IC50 = 12.76 µM和12.97 µM)。 结论:发现化合物9具有显着的抗乳腺癌活性。进一步评估该化合物在5和10 µM浓度下对乳腺癌细胞MCF-7的侧群抑制百分比测定。与参考药物
维拉帕米相比,在5μM浓度下,它显示出对阻止侧群的优势超过80%。